Radiolabeling and in vivo behavior of copper-64-labeled cross-bridged cyclam ligands.
about
Comparison of (64)Cu-complexing bifunctional chelators for radioimmunoconjugation: labeling efficiency, specific activity, and in vitro/in vivo stability.Metal complexes of cyclen and cyclam derivatives useful for medical applications: a discussion based on thermodynamic stability constants and structural data.Macrocyclic diamide ligand systems: potential chelators for 64Cu- and 68Ga-based positron emission tomography imaging agents.A heterodimeric [RGD-Glu-[(64)Cu-NO2A]-6-Ahx-RM2] αvβ3/GRPr-targeting antagonist radiotracer for PET imaging of prostate tumorsThe copper radioisotopes: a systematic review with special interest to 64Cu.Synthesis and biological evaluation of copper-64 radiolabeled [DUPA-6-Ahx-(NODAGA)-5-Ava-BBN(7-14)NH2], a novel bivalent targeting vector having affinity for two distinct biomarkers (GRPr/PSMA) of prostate cancer.Evaluation of 64Cu labeled GX1: a phage display peptide probe for PET imaging of tumor vasculatureCoordinating radiometals of copper, gallium, indium, yttrium, and zirconium for PET and SPECT imaging of diseaseBridged cyclams as imaging agents for chemokine receptor 4 (CXCR4)Novel hexadentate and pentadentate chelators for ⁶⁴Cu-based targeted PET imaging64Cu-labeled alpha-melanocyte-stimulating hormone analog for microPET imaging of melanocortin 1 receptor expression.Evaluation of a (64)Cu-labeled cystine-knot peptide based on agouti-related protein for PET of tumors expressing alphavbeta3 integrinLiposomal Cu-64 labeling method using bifunctional chelators: poly(ethylene glycol) spacer and chelator effects.Inorganic chemistry in nuclear imaging and radiotherapy: current and future directions.In vitro and in vivo evaluation of ⁶⁴Cu-radiolabeled KCCYSL peptides for targeting epidermal growth factor receptor-2 in breast carcinomas.Preparation and biological evaluation of (64)Cu labeled Tyr(3)-octreotate using a phosphonic acid-based cross-bridged macrocyclic chelatorCross-bridged macrocyclic chelators for stable complexation of copper radionuclides for PET imaging.The long and short of it: the influence of N-carboxyethyl versusN-carboxymethyl pendant arms on in vitro and in vivo behavior of copper complexes of cross-bridged tetraamine macrocycles.Improved PET imaging of uPAR expression using new (64)Cu-labeled cross-bridged peptide ligands: comparative in vitro and in vivo studies.Macrocyclic chelator assembled RGD multimers for tumor targeting.Synthesis and characterization of the copper(II) complexes of new N2S2-donor macrocyclic ligands: synthesis and in vivo evaluation of the (64)Cu complexes.[64Cu-NOTA-8-Aoc-BBN(7-14)NH2] targeting vector for positron-emission tomography imaging of gastrin-releasing peptide receptor-expressing tissuesIn vitro and in vivo evaluation of a 64Cu-labeled NOTA-Bn-SCN-Aoc-bombesin analogue in gastrin-releasing peptide receptor expressing prostate cancer.Copper(II) cyclam-based complexes for radiopharmaceutical applications: synthesis and structural analysisThe efficient synthesis and biological evaluation of novel bi-functionalized sarcophagine for (64)cu radiopharmaceuticals.Synthesis, Cu(II) complexation, 64Cu-labeling and biological evaluation of cross-bridged cyclam chelators with phosphonate pendant armsCopper-64 radiolabeling and biological evaluation of bifunctional chelators for radiopharmaceutical developmentTransferrin conjugates of triazacyclononane-based bifunctional NE3TA chelates for PET imaging: Synthesis, Cu-64 radiolabeling, and in vitro and in vivo evaluation.Synthesis of a cross-bridged cyclam derivative for peptide conjugation and 64Cu radiolabeling.Copper-64 Radiopharmaceuticals for Oncologic ImagingH(2)azapa: a versatile acyclic multifunctional chelator for (67)Ga, (64)Cu, (111)In, and (177)LuA practical guide to the construction of radiometallated bioconjugates for positron emission tomography.(64)Cu-labeled CB-TE2A and diamsar-conjugated RGD peptide analogs for targeting angiogenesis: comparison of their biological activity64Cu-AMD3100--a novel imaging agent for targeting chemokine receptor CXCR4.Molecular imaging of cancer with copper-64 radiopharmaceuticals and positron emission tomography (PET).Promising bifunctional chelators for copper 64-PET imaging: practical (64)Cu radiolabeling and high in vitro and in vivo complex stability.Copper-64 radiopharmaceuticals for PET imaging of cancer: advances in preclinical and clinical research.Zirconium tetraazamacrocycle complexes display extraordinary stability and provide a new strategy for zirconium-89-based radiopharmaceutical development.Efficient preparation and biological evaluation of a novel multivalency bifunctional chelator for 64Cu radiopharmaceuticalsPeptides in receptor-mediated radiotherapy: from design to the clinical application in cancers.
P2860
Q27339846-94F1D068-E364-4AE0-AF63-C5AA92A1B6AAQ31116849-24FC73BC-C454-404E-B9FF-31BCF3B31806Q33480211-A614236C-87E8-419F-BE05-35DF15C7BEC6Q33616878-B2791E39-A8C1-425B-A0A0-956CEA8D7DF5Q33661508-29E3CEB9-9B05-4D43-AE61-05BED17F0ECEQ33699158-E16A20D9-0753-4599-8635-FC6C9C0EB480Q33832487-34E3E917-C260-45AF-8817-7E06FA5C2590Q33870879-71036D5B-5F16-479E-84A3-B6A80D416D5DQ33924007-8D013C40-6602-401B-8F9C-B8214BC28E85Q34072844-D0C97EC2-5EE7-4B6E-8612-C8DE831545BBQ34083332-641D948E-6A38-48A1-919A-99087DBF8E82Q34083412-25780C1B-11F1-4AEB-9F45-E8F12E1D7D11Q34144898-46EC44DD-0BA5-4EDC-B3F2-B1D2FF207FF4Q34460892-566F3E79-5B87-4F17-8FEA-F94AB351BCC4Q34519479-08F32175-0E2F-4C94-8AAB-2030C77DBC3FQ34677178-1F596C77-E140-43D0-9716-7FE283DEB90FQ34866598-DBDC0EF8-50A9-459C-B80E-EF2004DF52ACQ34901742-AE27558E-70B3-4679-83F9-9DB575AC2E68Q34992753-562B42A8-2EB1-429F-AF32-161A8AC486D7Q34995512-014E2EB9-418B-4831-80EE-6F7BEAC07712Q35565660-1DE713B6-832D-4429-98F4-3890F135926FQ35881049-447576A4-E98F-4FFB-B463-441E0BDE9852Q35925945-FE98BABE-A558-4222-A8D2-5E88CA0A24AFQ35994738-70D59C72-0717-4DAC-8DAB-FAC37EF79BDDQ36052972-86BBCD9F-73EC-428E-A1B7-F1477FF263F2Q36291655-0845BF77-BA84-4C52-B24C-3B24F2D1B5BEQ36315404-1B19DE3B-ECC5-48FF-8550-D347264E7931Q36372777-94B79DE5-1D64-4EB6-A38A-8525359F0BAEQ36826058-ED49E49E-1FB9-4517-A6A9-7AFFF8A43101Q37126530-16124FBF-5A2E-4C83-A0FD-82D8788F6C00Q37142624-5BCAF0FD-7906-4399-95A9-422BD7F6E635Q37172093-13464D29-D5C0-400C-88AA-556C202074CCQ37218456-4C57A033-9E82-40D5-BE3C-3C0925CFB814Q37297085-27105E12-541A-4CE8-B7F7-7291645AA08CQ37356557-2A927181-2CAB-44DD-BB9C-E096B3B7C784Q37424123-CE7CF057-DD87-4C79-80E6-261B176D4320Q37478003-5037CD66-D4A2-4F65-BCD1-86EC15E2E388Q37718007-DA2B8235-7645-4263-B98E-84B53A68DA76Q37722948-40BF157B-474B-4619-A8A7-F914AA137CB9Q38149131-41648179-3F71-4AF1-A014-89F3DB3AB532
P2860
Radiolabeling and in vivo behavior of copper-64-labeled cross-bridged cyclam ligands.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Radiolabeling and in vivo behavior of copper-64-labeled cross-bridged cyclam ligands.
@en
Radiolabeling and in vivo behavior of copper-64-labeled cross-bridged cyclam ligands.
@nl
type
label
Radiolabeling and in vivo behavior of copper-64-labeled cross-bridged cyclam ligands.
@en
Radiolabeling and in vivo behavior of copper-64-labeled cross-bridged cyclam ligands.
@nl
prefLabel
Radiolabeling and in vivo behavior of copper-64-labeled cross-bridged cyclam ligands.
@en
Radiolabeling and in vivo behavior of copper-64-labeled cross-bridged cyclam ligands.
@nl
P2093
P356
P1476
Radiolabeling and in vivo behavior of copper-64-labeled cross-bridged cyclam ligands
@en
P2093
Arthur E Martell
David P Reed
Edward H Wong
Gary R Weisman
Melinda Wuest
Michael J Welch
Ramunas Motekaitis
Xiankai Sun
P304
P356
10.1021/JM0103817
P407
P577
2002-01-01T00:00:00Z